←
Nicola Pozzi317 posts
Nicola Pozzi avatar

Nicola Pozzi

@LabPozzi

Associate Professor St. Louis University School of Medicine researching #antiphospholipid Syndrome, mechanisms of blood clotting, next-gen #antithrombotics

◷ Joined August 2018▧ 7 Photos and videos
Krista Lentine, MD,PhD | FASN | FAST avatar
⟳ Nicola Pozzi retweeted
Krista Lentine, MD,PhD | FASN | FAST@KristaLentine·20 Sep 2025

🏅Celebrating 50 Years of Service: Honoring Dr. Terry Moore’s Legacy in #Rheumatology | @SSMHealthSTL #InternalMedicine 🩺🏥 🫶🏼The IM Department is privileged to celebrate Dr. Moore’s remarkable 50 years of dedication and leadership in building the legacy of our Rheumatology division. Over the past five decades, Dr. Moore has: 🔹 Pioneered approaches that have shaped how #autoimmune diseases are diagnosed and managed. 🔹 Mentored countless trainees, faculty, and colleagues who continue to carry his impact forward. 🔹 Contributed groundbreaking insights into the role of laboratory studies + the art of clinical diagnosis in guiding patient care. Beyond his scientific and clinical achievements, Dr. Moore’s commitment to #mentorship, #collaboration, & #innovation has left a lasting mark on our institution and the broader medical community. 🌟 🙏🏽 @RaviNayakMD➕Sally Day➕others for organizing a special event including Dr. Moore's #GrandRounds lecture on ‘Autoimmunity and Laboratory Studies in Connective Tissue Disease’, tributes & networking 🤝🏽 August 22, 2025 🫶🏼 Dr. Raymond Slavin for heartfelt tribute to Dr. Moore 🎤 Please join us in celebrating Dr. Moore's extraordinary career & enduring contributions to research, education, and patient care. 👏🏽 #SLUProud #SLUResearch #Rheumatology #ConnectiveTissueDisease #MedicalEducation #Mentorship #CelebratingExcellence | @SLU_Official | @slusom | @SSMHealth | @nephrom | @renginels | @Barisafsar75 | @GkamelMD | @sagun_goyal | @linamariat50445 🩺🏥

Post attachment
aHUS Alliance Action avatar
⟳ Nicola Pozzi retweeted
aHUS Alliance Action@aHUSAllianceAct·19 Sep 2025

New insights to consider in the clinical approach to #TMA: rpthjournal.org/article/S247… On the lack of response to #complement blockade therapy and high rates of recurrence among patients with #plasminogen variants. #anticoagulation #cmTMA @anuja_java

APS_ACTION avatar
⟳ Nicola Pozzi retweeted
APS_ACTION@APS_ACTION·12 Sep 2025

Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.

Post attachmentPost attachment
BIDMC avatar
⟳ Nicola Pozzi retweeted
BIDMC@BIDMChealth·12 Sep 2025

Is someone you love at risk for an aortic aneurysm? This Aortic Disease Awareness Month, take a moment to learn the risk factors, understand who should be screened, and find out how testing can help save lives: bidmc.org/aorticscreening

0:18
flora peyvandi avatar
⟳ Nicola Pozzi retweeted
flora peyvandi@flora_peyvandi·11 Sep 2025

Did you know that #Plasminogen activation and plasmin activity are not necessary to #prevent venous thrombosis/thromboembolism ashpublications.org/blood/ar…

ASH avatar
⟳ Nicola Pozzi retweeted
ASH@ASH_hematology·18 Jun 2025

ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards

0:18
Eric Mullins avatar
⟳ Nicola Pozzi retweeted
Eric Mullins@ericsmullins·18 Nov 2024

I have had the honor of serving on the @HTRStoday 2025 Scientific Symposium planning committee over the last year. There is going to be a great program. We have a record number of abstracts submitted. Make plans now to attend in March 2025!!

Post attachment
Nicola Pozzi avatar
Nicola Pozzi@LabPozzi·15 Nov 2024

Life is a melody, with enzymes as instruments and ligands as music directors. We show how two ligands binding to the same pocket of an enzyme can produce different melodies—the magic of allostery! Great job, Ponzar, Chinnaraj et al. @SLUbiochem, @HemeThrombBIDMC, and @UniPadova

JTH@JTHjournal12 Nov 2024

Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of PDI-targeting drug. ✍️@LabPozzi jthjournal.org/article/S1538…

Post attachment
JTH avatar
⟳ Nicola Pozzi retweeted
JTH@JTHjournal·12 Nov 2024

Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of PDI-targeting drug. ✍️@LabPozzi jthjournal.org/article/S1538…

Post attachment